Big Rock Partners Acquisition Corp

Big Rock Partners Acquisition Corp was a blank-check company sponsored by Big Rock Partners that filed its S-1 registration statement with the SEC in October 2017, targeting the healthcare and life sciences sector. The vehicle completed its initial public offering in 2017 and subsequently executed a business combination with NeuroRx, Inc., a clinical-stage biopharmaceutical company, resulting in a combined entity that operates under the Nasdaq ticker NRXP, now known as NRx Pharmaceuticals. The deal represented an early example of SPAC activity in the specialty pharma space during the pre-boom era. Sign up on SpacDesk for full filing history, deal timelines, and post-combination data on NRXP and thousands of other SPAC transactions.